RXi Pharmaceuticals Performance
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and RXi Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days RXi Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong forward indicators, RXi Pharmaceuticals is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
| Fifty Two Week Low | 0.3200 | |
| Fifty Two Week High | 0.3320 |
RXi |
RXi Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest (100.00) in RXi Pharmaceuticals on January 26, 2024 and sell it today you would earn a total of 100.00 from holding RXi Pharmaceuticals or generate -100.0% return on investment over 90 days. RXi Pharmaceuticals is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than RXi, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
RXi Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for RXi Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as RXi Pharmaceuticals, and traders can use it to determine the average amount a RXi Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| RXII |
Based on monthly moving average RXi Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of RXi Pharmaceuticals by adding RXi Pharmaceuticals to a well-diversified portfolio.
RXi Pharmaceuticals Fundamentals Growth
RXi Stock prices reflect investors' perceptions of the future prospects and financial health of RXi Pharmaceuticals, and RXi Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on RXi Stock performance.
| Return On Equity | -294.79 | |||
| Return On Asset | -96.79 | |||
| Current Valuation | (1.77 M) | |||
| Shares Outstanding | 18.16 M | |||
| Price To Earning | (0.54) X | |||
| Price To Book | 0.84 X | |||
| Price To Sales | 39.20 X | |||
| Revenue | 153 K | |||
| EBITDA | (7.54 M) | |||
| Cash And Equivalents | 3.24 M | |||
| Cash Per Share | 0.73 X | |||
| Debt To Equity | 0.26 % | |||
| Book Value Per Share | 0.39 X | |||
| Cash Flow From Operations | (7.97 M) | |||
| Earnings Per Share | (2.29) X | |||
| Total Asset | 11.16 M | |||
| Retained Earnings | (57.1 M) | |||
| Current Asset | 10.98 M | |||
| Current Liabilities | 2.27 M | |||
Things to note about RXi Pharmaceuticals performance evaluation
Checking the ongoing alerts about RXi Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for RXi Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| RXi Pharmaceuticals is not yet fully synchronised with the market data | |
| RXi Pharmaceuticals has some characteristics of a very speculative penny stock | |
| RXi Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 153 K. Net Loss for the year was (7.63 M) with loss before overhead, payroll, taxes, and interest of (5.36 M). | |
| RXi Pharmaceuticals currently holds about 3.24 M in cash with (7.97 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73. |
- Analyzing RXi Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether RXi Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining RXi Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating RXi Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of RXi Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of RXi Pharmaceuticals' stock. These opinions can provide insight into RXi Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in RXi Stock
If you are still planning to invest in RXi Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RXi Pharmaceuticals' history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |